Failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse (in absence of known reason) in a couple who have never had a child
Aetiology
Definitions
- Either primary (couple never conceived) or secondary (couple previously conceived, although pregnancy may not have been successful e.g. miscarriage, ectopic pregnancy)
- Infertility is classed as a disease as it causes considerable psychological distress
Factors which increase chance of conception
- Women under 30
- Previous pregnancy
- Less than 3 years trying to conceive
- Intercourse occuring around ovulation
- Woman's BMI 18.5-30 m/kg2
- Both partners non-smokers
- Caffeine intake of less than 2 cups a day
- No recreational drug use
Causes of female infertility
Anovulatory infertility
- Infertility due to lack of ovulation
- Physiological
- Before puberty, pregnancy, lactation, menopause
- Gynaecological conditions
- Hypothalamic: anorexia/bulimia, excessive exercise, stress, Kallman's syndrome
- Pituitary: hyperprolactinaemia, tumours, Sheehan syndrome
- Ovarian: PCOS, premature ovarian failure
- Others
- Systemic disorder e.g. chronic renal failure
- Endocrine disorder e.g. testosterone secreting tumours, congenital adrenal hyperplasia, thyroid
- Drugs e.g. depo-provera, explanon, OCP
Common causes of secondary infertiliy
- Tubal disease
- Fibroids
- Endometriosis/adenomyosis
- Weight related
- Age related
Causes of male infertility
- Approx. 30-50% idiopathic
- Environmental and lifestyle factors are risk factors e.g. occupational, smoking, alcohol, obesity
Non-obstructive
- e.g. 47 XXY (Klinefelter), chemotherapy, radiotherapy, undescended testes, idiopathic, endocrine causes (hypogonadotrophic hypogonadism, hypothyroidism, hyperprolactinaemia, diabetes)
- Clinical features:
- Low testicular volume
- Reduced secondary sexual characteristics
- Vas deferens present
- Endocrine features: high LH and FSH, low testosterone
Obstructive
- e.g. congenital absence (CF), infection, vasectomy
- Clinical features:
- Normal testicular volume
- Normal secondary sexual characteristics
- Vas deferens may be absent
- Endocrine features: normal LH, FSH and testosterone
Clinical presentation
History taking (male and female)
- Infertility history
- Gynaecology
- Andrology
- PMHx, PSHx, POHx - ask about menstrual cycle for female
- Sexual history
- Social history
Examination - female
- BMI
- General examination, assessing body hair distribution, galactorrhoea
- Pelvic examination, assessing for uterine and ovarian abnormalities/tenderness/mobility
Examination - male
- BMI
- General examination
- Genital examination, assessing size/position testes, penile abnormalities, presence of vas deferens, presence of varicoceles
Investigations
Primary care investigations
Female
- Assessing ovulation
- Regular cycles very suggestive of ovulation
- Confirm with midluteal progesterone level - day 21 of 28 day cycle or 7 days prior to expected period in prolonged cycles
- Irregular cycles - likely anovulatory, needs further hormone evaluation
- Blood for rubella immunity
- Checking for rubella IgG (immunity) is important as if mother contracts rubella while pregnant there is a 50% chance baby will get rubella syndrome - effects include microcephaly, patent ductus arteriosus, cateracts
- Can be avoided by giving MMR booster
- TSH
- Endocervical swab for chlamydia
- If a woman has one untreated chlamydia infection, the chances of tubal block is 10%
- Cervical smear if due
- If amenorrhoeic/cycle longer than 42 days:
- Follicular phase bloods: LH, FSH, E2
- Testosterone, SHBG, FAI
- Prolactin
Male
- Diagnostic semen analysis - twice over 6 weeks apart
- Azoopermia: no sperm in ejaculate
- Asthenozoospermia: % progressive motile sperm below reference limit
- Oligozoospermia: total number/concentration of sperm below reference limit
- Teratozoospermia: % morphologically normal sperm below reference limit
Infertility consultation
- Patients seen as a couple
- Establish length of relationship, and length of time trying to get pregnant
Investigations for female
- Ultrasound - abnormal findings include congenital uterine abnormalities, fibroids, endometrial polyp, hydrosalpinx, PCOS, ovarian cyst
- Tubal patency testing
- Hysterosalpingiogram (HSG)/hycosy - if no known risk factors for tubal or pelvic pathology, or if laproscopy contraindicated
- Diagnostic laproscopy - if possible tubal/pelvic disease, known previous pathology, history suggestive of pathology or previously abnormal HSG
- Contraindicated in obesity, previous pelvic surgery, Crohn's disease
- Hysteroscopy - only performed in cases where there is suspected/known endometrial pathology
Investigations for male
- If abnormal semen analysis: LH and FSH, testosterone, prolactin, thyroid function
- If severely abnormal semen analysis/azoospermic:
- Endocrine profile as in abnormal semen
- Chromosome analysis and Y chromosome microdeletions
- Screen for cystic fibrosis
- Testicular biopsy
- If abnormality on genital examination:
- Scrotal US
Management
Lifestyle advice
- Stop smoking
- Achieve BMI between 18.5 and 30
- Reduce/stop alcohol intake
- Take caffeine containing drinks in moderation only
- Stop recreational drugs
- Stop taking methodone
General advice
- Reassurance - 95% will conceive within 36 months of unprotected sex
- Advise sexual intercourse every 2-3 days rather than timing intercourse with the menstrual cycle
- Consider underlying psychosexual problems
- Consider need for preconception counselling if pre-existing medical condition e.g. euglycaemic control if women diabetic
Management of female infertility
Vitamin supplements for women
- Folic acid - 400 micrograms daily before pregnancy and for first 12 weeks (5 milligrams in some cases e.g. woman or or their partner have a damily history of neural tube defects)
- Vitamin D - 10 micrograms per day for pregnant or lactating women
Pre-fertility treatment
- Stabilise weight - BMI >18.5 and <30
- Lifestyle modification - smoking, alcohol
- Folic acid 400 mcg daily, 5mg daily if BMI over 30
- Check prescribed drugs
- Check rubella immunity
- Normal semen analysis
- Patent fallopian tube
Management of any underlying cause
- Treat any cause of fertility issues e.g. ovulation disorders
- PCOS is the most common reason for ovulatory problems → ovulation induction
- Clomifene citrate/letrozole first line for ovulation induction, gonadotrophin injections and laproscopic ovarian diathermy are other options
- If clomifene resistant: weight loss, consider adjuvant metformin
Surgical treatment
- Reproductive surgery may be the primary treatment of infertility e.g. devision of pelvic adhesions, removal of tubal block and removal of polyps/fibroids
- Surgery can also be used to enhance IVF treatment
- Women with hydrosalpinges (fallopian tube filled with water) should be offered laparoscopic salpingectomy before IVF treatment as this improves pregnancy rate and reduces miscarriage rate
- Abnormalities in the uterine cavity should be treated before IVF
Management of male infertility
- There are only a few treatable causes e.g. prescribed drugs, surgery to obstructed vas deferens, hormonal conditions
- Treatment mainly rests with ART
- Intrauterine insemitation in mild disease
- Intracytopalsmic sperm injection (ICSI) - microinjection of the sperm into the egg
- Surgical sperm aspiration (surgical sperm recovery) from epididymis or testicle combined with ICSI
- Donor sperm insemination if no sperm found in aspiration
Assisted conception
- Pre IVF workup
- Ovarian stimulation (hormonal injection)
- Monitoring
- Ovulation induction
- Oocyte removal
- Preparation of sperms
- In vitro ferilization
- Embryo transfer - once embryo reaches the blastocyst stage (day 5)
- Luteal support
Risks of ovulation induction/assisted conception
- Ovarian hyperstimulation
- Usually occurs in women taking injectable hormone medication e.g. ovulation induction, IVF
- Affects up to 10% of IVF cycles
- Ranges from mild-severe
- Increased risk if <35 years, PCOS
- Multiple pregancy
- Increased maternal and pregnancy complications, as well as risk for babies
- Theoretical risk of ovarian cancer